Oversea-Chinese Banking Corp (OCBC)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Oversea-Chinese Banking Corp (OCBC)'s PFE Position: Q2 2026 in Review
Oversea-Chinese Banking Corp (OCBC) increased its Pfizer (PFE) stake by 19% in Q2 2026, buying an estimated $355K and bringing the position to 83,573 shares worth $2.01M. The position accounts for 0.04% of the portfolio, ranked #198.
Oversea-Chinese Banking Corp (OCBC) first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Oversea-Chinese Banking Corp (OCBC) held 83,573 shares of Pfizer worth $2.01M as of Q2 2026.
- Oversea-Chinese Banking Corp (OCBC) bought 13,567 Pfizer shares in Q2 2026, an estimated $355K.
- Pfizer made up 0.04% of Oversea-Chinese Banking Corp (OCBC)'s portfolio in Q2 2026, its #198 holding.
- Oversea-Chinese Banking Corp (OCBC) first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
- 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q2 2026, filed 11 Aug 2026.